Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Net Income (Quarterly): -18.76M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -18.76M |
| June 30, 2024 | -14.13M |
| March 31, 2024 | -12.93M |
| December 31, 2023 | -11.73M |
| September 30, 2023 | -8.288M |
| June 30, 2023 | -13.95M |
| March 31, 2023 | -12.79M |
| December 31, 2022 | -13.60M |
| September 30, 2022 | -6.286M |
| Date | Value |
|---|---|
| June 30, 2022 | -5.315M |
| March 31, 2022 | -7.519M |
| December 31, 2021 | -7.146M |
| September 30, 2021 | -10.33M |
| June 30, 2021 | -8.363M |
| March 31, 2021 | -6.831M |
| June 30, 2020 | -2.114M |
| March 31, 2020 | -2.626M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.76M
Minimum
Sep 2024
-2.114M
Maximum
Jun 2020
-9.572M
Average
-8.363M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Galapagos NV | -55.46M |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -11.19M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.392M |
| Total Expenses (Quarterly) | 17.87M |
| EPS Diluted (Quarterly) | -0.5455 |
| Enterprise Value | 241.66M |
| Gross Profit Margin (Quarterly) | 61.93% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -23.32% |
| Normalized Earnings Yield | -22.45 |